Welcome to our dedicated page for Oriental Rise SEC filings (Ticker: ORIS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Oriental Rise Holdings Limited (NASDAQ: ORIS) files reports and updates with the U.S. Securities and Exchange Commission as a foreign private issuer. These SEC filings provide detailed information on the company’s vertically integrated tea operations in mainland China, its financial performance, capital structure, and corporate actions.
Among the key documents available are Form 6-K current reports. In its interim 2025 results furnished on Form 6-K, Oriental Rise presents revenue by product category, including primarily-processed white tea, primarily-processed black tea, and refined tea, and explains how changes in selling prices, sales volumes, and market conditions have affected revenue, gross profit, and margins. The filing also breaks down cost of sales into plantation and processing costs, and describes the components of selling and distribution costs and administrative expenses, offering insight into the company’s cost structure.
Other 6-K filings cover capital markets transactions, such as the pricing of public offerings of units consisting of ordinary shares and warrants, the terms of those warrants, and intended uses of proceeds for sales network expansion, production and capacity expansion, and working capital. Filings also document corporate governance and capital structure changes, including shareholder approvals for increasing authorized share capital, designating Founder Preferred Shares with enhanced voting rights, issuing those shares to a company owned by the founder and largest shareholder, and authorizing a potential share consolidation within a defined ratio range.
Regulatory compliance and listing status are addressed in filings that describe Nasdaq notifications regarding the minimum bid price requirement and the company’s potential options, including a reverse stock split, to regain compliance. Board and management changes, such as director resignations and appointments, are also reported through Form 6-K.
On Stock Titan’s SEC filings page for ORIS, users can access these documents as they are furnished to EDGAR and review AI-powered summaries that highlight key sections. These summaries can help explain complex tables, capital structure terms, and narrative disclosures in plain language, while links to the underlying filings allow for deeper analysis of Oriental Rise’s financial results, corporate actions, and ongoing reporting obligations.
Oriental Rise Holdings Limited is offering a firm commitment primary offering of 7,730,227 Units, each Unit consisting of one Ordinary Share (or one Pre-Funded Warrant in lieu of a share) and one Common Warrant. Each Common Warrant initially exercisable at
Oriental Rise Holdings Limited reports the creation and issuance of a new class of Founder Preferred Shares that concentrate voting power with its founder. On November 19, 2025, the board used its authority to designate 2,500,000 authorized but unissued shares as Founder Preferred Shares and issue them to Plentiful Thriving (BVI) Limited, a company 100% owned by founder and largest shareholder Chun Sun Wong.
These Founder Preferred Shares are non-convertible, non-redeemable, non-transferable and carry no economic rights beyond voting, but each share has 1,000 votes. Following a 1-for-20 reverse split effective December 30, 2025, there are 125,000 Founder Preferred Shares outstanding, together entitled to 125,000,000 votes. The company also held an Extraordinary General Meeting on February 14, 2026, at which shareholders approved resolutions adopting Amended and Restated Memorandum and Articles of Association, which were filed on February 16, 2026.
Oriental Rise Holdings Limited reports that it has regained compliance with Nasdaq’s minimum bid price requirement. Nasdaq confirmed that for the ten consecutive business days from December 30, 2025 through January 14, 2026, the closing bid price of the company’s ordinary shares was at least US$1.00 per share, satisfying Listing Rule 5550(a)(2).
This resolution closes the prior minimum bid price deficiency that had threatened its continued listing on The Nasdaq Capital Market. The company states that restoring compliance supports its commitment to strong corporate governance and to remaining listed on Nasdaq, and it plans to continue monitoring adherence to all applicable listing standards.
Oriental Rise Holdings Limited reported much weaker interim results for the six months ended June 30, 2025. Revenue fell to about
Gross profit shrank to
Administrative expenses rose to
Oriental Rise Holdings Limited reported that it held an Extraordinary General Meeting of shareholders on September 21, 2025. At this meeting, a majority of shareholders approved new governing documents in the form of an Amended and Restated Memorandum and Articles of Association. These updated corporate charter documents are provided as Exhibit 3.1 to the report, giving investors and other stakeholders access to the detailed terms that will now govern the company.
Oriental Rise (ORIS) priced a best-efforts public offering of 14.8 million units at US$0.4681 each, targeting gross proceeds of ~US$6.9 million. Each unit contains 1 ordinary share and 1 five-year warrant. Warrants are immediately exercisable at US$0.4681, include a cashless “zero-exercise” option that delivers 2× the shares otherwise issuable, and feature automatic repricing: to 70 % of the initial price on the 5th trading day (US$0.3276) and to 50 % on the 10th day (US$0.234); share count adjusts proportionately so the nominal aggregate exercise price stays unchanged.
Maxim Group LLC is exclusive placement agent, earning a 7 % fee plus up to US$100k expenses. Closing is expected on or about 23 Jul 2025. Securities are offered under an effective F-1 (No. 333-288292).
Use of proceeds
- 28 % – expand sales network
- 34 % – production & capacity upgrades
- 38 % – working capital
The deal supplies growth capital but materially expands potential share count, posing dilution and price-pressure risks if warrants are exercised at lower repriced levels.